PPARs regulate genes involved in lipid and glucose metabolism and inflammation (Montaigne, Butruille & Staels, 2021), and dysregulation of PPAR signaling has been observed in ICC patients (Liu et al., 2023), further strengthening the case for these pathways’ relevance to ICC. This evidence concerns the gene PPARA and intrahepatic cholangiocarcinoma.